Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
991
Total Claims
$65K
Drug Cost
194
Beneficiaries
$335
Cost/Patient
Risk Score Breakdown 10/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+4%
Opioid rate vs peers
47.6% vs 45.9% avg
-31%
Cost per patient vs peers
$335 vs $483 avg
+127%
Brand preference vs peers
9.4% vs 4.1% avg
Opioid Prescribing
47.6%
Opioid Rate
472
Opioid Claims
$40K
Opioid Cost
26.9%
Long-Acting Rate
This provider's opioid prescribing rate of 47.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 93 claims · $45K
Generic: 898 claims · $20K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 30 | $15K |
| Oxycodone Hcl | 11 | $13K |
| Bimatoprost | 20 | $5,393 |
| Icosapent Ethyl | 12 | $2,403 |
| Hydrocodone/Acetaminophen | 159 | $2,155 |
| Gabapentin | 112 | $2,054 |
| Oxycodone Hcl/Acetaminophen | 79 | $1,863 |
| Morphine Sulfate | 65 | $1,623 |
| Baclofen | 62 | $1,428 |
| Celecoxib | 20 | $908 |
| Oxycodone Hcl | 41 | $784 |
| Cyclobenzaprine Hcl | 39 | $381 |
| Duloxetine Hcl | 18 | $299 |
| Tizanidine Hcl | 26 | $269 |
| Methocarbamol | 33 | $262 |
Prescribing Profile
18
Unique Drugs
10.0
Anomaly Score
Patient Profile
71
Avg Age
57%
Female
1.54
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About